Brazil: Hypera Pharma EBITDA 2015-2019
In 2019, the Brazilian pharmaceutical company Hypera Pharma generated earnings before interests, taxes, depreciation, and amortization (EBITDA) of approximately 1.18 billion Brazilian reals, down from around 1.3 billion reals reached the year before. It is the first time since 2015 that this figure annually decreased.